SwePub - search: L773:0008 6363

Enumeration	Reference	Cover	Find
1.	Balogh, J, et al. (author) Hearts from mice lacking desmin have a myopathy with impaired active force generation and unaltered wall compliance 2002 In: Cardiovascular research. - 0008-6363. ; 53:2, s. 439-450 Journal article (peer-reviewed)
2.	Elhage, R, et al. (author) Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice 2003 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 59:1, s. 234-240 Journal article (peer-reviewed)
3.	Foreman, RD, et al. (author) Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris 2000 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 47:2, s. 367-375 Journal article (peer-reviewed)
4.	Gonon, AT, et al. (author) The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion 1998 In: Cardiovascular research. - 0008-6363. ; 39:3, s. 674-682 Journal article (peer-reviewed)
5.	GORDON, A, et al. (author) Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance 1995 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 30:3, s. 413-418 Journal article (peer-reviewed)
6.	Gordon, A (author) Creatine supplementation in chronic heart failure - Reply 1996 In: CARDIOVASCULAR RESEARCH. - 0008-6363. ; 31:1, s. 176-176 Journal article (other academic/artistic)
7.	Gourine, A, et al. (author) The short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardized myocardium 2001 In: EUROPEAN HEART JOURNAL. - 0195-668X. ; 51:1, s. 100-107 Conference paper (other academic/artistic)
8.	Holm, P, et al. (author) The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo 1998 In: Cardiovascular research. - 0008-6363. ; 37:3, s. 765-771 Journal article (peer-reviewed)
9.	HultgardhNilsson, A, et al. (author) Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture 1997 In: Cardiovascular research. - 0008-6363. ; 34:2, s. 418-430 Journal article (peer-reviewed)
10.	Kallner, G, et al. (author) Calcitonin gene-related peptide in myocardial ischaemia and reperfusion in the pig 1998 In: Cardiovascular research. - 0008-6363. ; 38:2, s. 493-499 Journal article (peer-reviewed)
11.	Magnusson, G, et al. (author) Peak skeletal muscle perfusion is maintained in patients with chronic heart failure when only a small muscle mass is exercised 1997 In: Cardiovascular research. - 0008-6363. ; 33:2, s. 297-306 Journal article (peer-reviewed)
12.	Malmberg, K, et al. (author) Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study 1997 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 34:1, s. 248-253 Journal article (peer-reviewed)
13.	Norata, GD, et al. (author) Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL 2003 In: Cardiovascular research. - 0008-6363. ; 59:1, s. 169-180 Journal article (peer-reviewed)
14.	Pernow, J (author) Adenosine as an important mediator of post-ischaemic neuronal stunning 2001 In: Cardiovascular research. - 0008-6363. ; 49:4, s. 693-694 Journal article (other academic/artistic)
15.	Pernow, J, et al. (author) Endothelin in myocardial ischaemia and reperfusion 1997 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 33:3, s. 518-526 Journal article (peer-reviewed)
16.	Tyni-Lenne, R, et al. (author) Female-related skeletal muscle phenotype in patients with moderate chronic heart failure before and after dynamic exercise training 1999 In: Cardiovascular research. - 0008-6363. ; 42:1, s. 99-103 Journal article (peer-reviewed)
17.	Uriuda, Y, et al. (author) Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosis 1996 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 32:2, s. 320-327 Journal article (peer-reviewed)
18.	Valen, G, et al. (author) Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFkappaB and AP-1 2000 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 47:1, s. 49-56 Journal article (peer-reviewed)
19.	VanWijk, MJ, et al. (author) Vascular function in preeclampsia 2000 In: Cardiovascular research. - 0008-6363. ; 47:1, s. 38-48 Journal article (peer-reviewed)
20.	WANG, QD, et al. (author) Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine 1995 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 29:1, s. 44-49 Journal article (peer-reviewed)
21.	Wang, QD, et al. (author) Pharmacological possibilities for protection against myocardial reperfusion injury 2002 In: Cardiovascular research. - 0008-6363. ; 55:1, s. 25-37 Journal article (peer-reviewed)
22.	WANG, QD, et al. (author) Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig 1995 In: Cardiovascular research. - : Oxford University Press (OUP). - 0008-6363. ; 29:6, s. 805-812 Journal article (peer-reviewed)
23.	Yang, CM, et al. (author) Changes in collagen phenotypes during progression and regression of cardiac hypertrophy 1997 In: Cardiovascular research. - 0008-6363. ; 36:2, s. 236-245 Journal article (peer-reviewed)
24.	Abdellatif, M, et al. (author) Co-ordinated mitochondrial degradation by autophagy and heterophagy in cardiac homeostasis 2021 In: Cardiovascular research. - : Oxford University Press (OUP). - 1755-3245 .- 0008-6363. ; 117:1, s. E1-E3 Journal article (peer-reviewed)
25.	Alabas, Oras A., et al. (author) Statistics on mortality following acute myocardial infarction in 842 897 Europeans 2020 In: Cardiovascular Research. - : OXFORD UNIV PRESS. - 0008-6363 .- 1755-3245. ; 116:1, s. 149-157 Journal article (peer-reviewed)abstract Aims: To compare ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) mortality between Sweden and the UK, adjusting for background population rates of expected death, case mix, and treatments.Methods and results: National data were collected from hospitals in Sweden [n = 73 hospitals, 180 368 patients, Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)] and the UK [n = 247, 662 529 patients, Myocardial Ischaemia National Audit Project (MINAP)] between 2003 and 2013. There were lower rates of revascularization [STEMI (43.8% vs. 74.9%); NSTEMI (27.5% vs. 43.6%)] and pharmacotherapies at time of hospital discharge including [aspirin (82.9% vs. 90.2%) and (79.9% vs. 88.0%), beta-blockers (73.4% vs. 86.4%) and (65.3% vs. 85.1%)] in the UK compared with Sweden, respectively. Standardized net probability of death (NPD) between admission and 1 month was higher in the UK for STEMI [8.0 (95% confidence interval 7.4-8.5) vs. 6.7 (6.5-6.9)] and NSTEMI [6.8 (6.4-7.2) vs. 4.9 (4.7-5.0)]. Between 6 months and 1 year and more than 1 year, NPD remained higher in the UK for NSTEMI [2.9 (2.5-3.3) vs. 2.3 (2.2-2.5)] and [21.4 (20.0-22.8) vs. 18.3 (17.6-19.0)], but was similar for STEMI [0.7 (0.4-1.0) vs. 0.9 (0.7-1.0)] and [8.4 (6.7-10.1) vs. 8.3 (7.5-9.1)].Conclusion: Short-term mortality following STEMI and NSTEMI was higher in the UK compared with Sweden. Mid- and longer-term mortality remained higher in the UK for NSTEMI but was similar for STEMI. Differences in mortality may be due to differential use of guideline-indicated treatments.

Skapa referenser, mejla, bekava och länka

Permalink

Träfflista för sökning "L773:0008 6363 "

Refine your search

Year